In 2024, CCO reviewers continue to make outstanding contributions to the peer review process. They demonstrated professional effort and enthusiasm in their reviews and provided comments that genuinely help the authors to enhance their work.

Hereby, we would like to highlight some of our outstanding reviewers, with a brief interview of their thoughts and insights as a reviewer. Allow us to express our heartfelt gratitude for their tremendous effort and valuable contributions to the scientific process.

January, 2024
Daniel Breadner, Schulich School of Medicine, Canada

January, 2024

Daniel Breadner

Dr. Dan Breadner, MD, FRCPC, is clinical researcher, medical oncologist and assistant professor at the London Regional Cancer Program at the Schulich School of Medicine. He treats lung and gastrointestinal cancers and has a research interest in translational and clinical research focusing on targeted therapy, liquid biopsies and immunomodulation. Connect with him on X @DrDanBreadner.

When reviewing clinical research, Dr. Breadner tries to both assess the validity of the paper and edit the manuscript to make it better. When editing, he would keep himself engaged on every point, allowing him to analyze the details better. Of course, it is important to assess the methods and to critically analyze the manuscript, but he would like to think that all papers he recommends for publication are stronger after the review.

Dr. Breadner thinks it is important to consider peer reviewing to be a part of the job. Noting that manuscripts may not be published by the first journal they are submitted to, he sets a minimum of two peer reviews for each manuscript he submits. He adds, “Without reviewers’ knowledge, dissemination would stop, so it is fair. The harder aspect is that reviewing requires focused time, so it competes for time with the other projects that often get done outside of normal workhours.”

(By Lareina Lim, Brad Li)